Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Inventory (2016 - 2025)

AtriCure (ATRC) has disclosed Inventory for 16 consecutive years, with $78.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory rose 4.19% to $78.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $78.5 million, a 4.19% increase, with the full-year FY2025 number at $78.5 million, up 4.19% from a year prior.
  • Inventory was $78.5 million for Q4 2025 at AtriCure, down from $79.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $79.0 million in Q3 2025 to a low of $36.1 million in Q1 2021.
  • A 5-year average of $58.2 million and a median of $58.7 million in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: surged 47.82% in 2023, then increased 3.14% in 2025.
  • AtriCure's Inventory stood at $39.0 million in 2021, then rose by 17.88% to $45.9 million in 2022, then surged by 47.82% to $67.9 million in 2023, then rose by 10.95% to $75.3 million in 2024, then increased by 4.19% to $78.5 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Inventory are $78.5 million (Q4 2025), $79.0 million (Q3 2025), and $76.3 million (Q2 2025).